Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales Montero, F., Lo, K., . . . Tabrizi, S. J. (2019). MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1.
Chicago Style CitationFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
MLA CitationFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
Warning: These citations may not always be 100% accurate.